Cantor Fitzgerald set a $107.00 target price on Perrigo (NYSE:PRGO) in a research report sent to investors on Friday, January 5th. The brokerage currently has a buy rating on the stock.
Other analysts also recently issued reports about the company. BidaskClub downgraded Perrigo from a hold rating to a sell rating in a report on Thursday, October 26th. Deutsche Bank lifted their price target on Perrigo from $88.00 to $95.00 and gave the stock a buy rating in a report on Thursday, September 14th. Canaccord Genuity reaffirmed a buy rating and set a $100.00 price target (up from $88.00) on shares of Perrigo in a report on Wednesday, September 13th. Jefferies Group set a $71.00 price target on Perrigo and gave the stock a hold rating in a report on Sunday, October 29th. Finally, CIBC initiated coverage on Perrigo in a report on Thursday, September 7th. They set an outperform rating and a $88.00 price target for the company. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the stock. Perrigo has an average rating of Hold and an average target price of $92.00.
Perrigo (NYSE PRGO) traded up $0.56 on Friday, reaching $95.15. The company had a trading volume of 975,706 shares, compared to its average volume of 994,253. Perrigo has a 1 year low of $63.68 and a 1 year high of $95.93. The firm has a market cap of $13,320.00, a PE ratio of -10.39, a price-to-earnings-growth ratio of 2.01 and a beta of 0.64. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.72 and a quick ratio of 1.24.
Perrigo (NYSE:PRGO) last released its earnings results on Thursday, November 9th. The company reported $1.39 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.11 by $0.28. Perrigo had a positive return on equity of 11.60% and a negative net margin of 26.28%. The firm had revenue of $1.22 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the previous year, the firm posted $1.65 EPS. Perrigo’s revenue for the quarter was down 2.0% on a year-over-year basis. equities research analysts anticipate that Perrigo will post 4.89 EPS for the current year.
In other news, EVP John Wesolowski sold 388 shares of the business’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $87.20, for a total value of $33,833.60. Following the completion of the sale, the executive vice president now directly owns 248 shares of the company’s stock, valued at approximately $21,625.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Todd W. Kingma sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 28th. The shares were sold at an average price of $88.52, for a total value of $132,780.00. Following the sale, the vice president now directly owns 19,565 shares of the company’s stock, valued at $1,731,893.80. The disclosure for this sale can be found here. Insiders sold a total of 4,051 shares of company stock valued at $355,370 over the last three months. Company insiders own 6.90% of the company’s stock.
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Perrigo by 2.1% during the 2nd quarter. Vanguard Group Inc. now owns 14,874,096 shares of the company’s stock valued at $1,123,292,000 after acquiring an additional 299,328 shares during the last quarter. State Street Corp raised its stake in Perrigo by 1.7% during the 2nd quarter. State Street Corp now owns 6,757,086 shares of the company’s stock valued at $510,294,000 after acquiring an additional 112,287 shares during the last quarter. Greenlight Capital Inc. increased its position in Perrigo by 14.8% during the 3rd quarter. Greenlight Capital Inc. now owns 2,901,032 shares of the company’s stock worth $245,572,000 after purchasing an additional 374,032 shares during the period. Parnassus Investments CA increased its position in Perrigo by 7.1% during the 3rd quarter. Parnassus Investments CA now owns 2,257,000 shares of the company’s stock worth $191,055,000 after purchasing an additional 150,000 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in Perrigo by 18.2% during the 2nd quarter. Goldman Sachs Group Inc. now owns 1,975,965 shares of the company’s stock worth $149,224,000 after purchasing an additional 304,950 shares during the period. 83.33% of the stock is owned by hedge funds and other institutional investors.
WARNING: “Perrigo (PRGO) Given a $107.00 Price Target at Cantor Fitzgerald” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The original version of this article can be viewed at https://www.dispatchtribunal.com/2018/01/28/perrigo-prgo-given-a-107-00-price-target-at-cantor-fitzgerald-3.html.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.